Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.

Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now lists 65 study locations, including new sites in Belgium, Germany, and Italy, and updates the trial date to 2025-03-03. The previous date of 2025-02-06 and the count of 62 locations have been removed.SummaryDifference2%
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now lists 62 study locations, an increase from 59, and includes new locations in Downey, California, Lille, France, and Paris, France. Additionally, there are updates regarding the study's status and heavy traffic affecting NLM-NCBI services.SummaryDifference4%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.